ArticleJournal of oncology2012

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.

José R Rossari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.